85 related articles for article (PubMed ID: 25896578)
1. Commercially available prognostic molecular models in early-stage lung cancer: a review of the Pervenio Lung RS and Myriad myPlan Lung Cancer tests.
Zheng Y; Bueno R
Expert Rev Mol Diagn; 2015 May; 15(5):589-96. PubMed ID: 25896578
[TBL] [Abstract][Full Text] [Related]
2. Prognostic modeling in early stage lung cancer: an evolving process from histopathology to genomics.
Harpole DH
Thorac Surg Clin; 2007 May; 17(2):167-73, viii. PubMed ID: 17626395
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review.
Singhal S; Vachani A; Antin-Ozerkis D; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Jun; 11(11):3974-86. PubMed ID: 15930332
[TBL] [Abstract][Full Text] [Related]
4. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
[TBL] [Abstract][Full Text] [Related]
5. Genomic prognostic models in early-stage lung cancer.
Kratz JR; Jablons DM
Clin Lung Cancer; 2009 May; 10(3):151-7. PubMed ID: 19443334
[TBL] [Abstract][Full Text] [Related]
6. Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancer.
Woodard GA; Gubens MA; Jahan TM; Jones KD; Kukreja J; Theodore PR; Cardozo S; Jew G; Clary-Macy C; Jablons DM; Mann MJ
Clin Lung Cancer; 2014 Nov; 15(6):426-32. PubMed ID: 25258195
[TBL] [Abstract][Full Text] [Related]
7. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
8. Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue.
Huang S; Reitze NJ; Ewing AL; McCreary S; Uihlein AH; Brower SL; Wang D; Wang T; Gabrin MJ; Keating KE; Mulligan J; Wilson C; Davison T; McKenzie S; Tsao MS; Shepherd FA; Plamadeala V
J Mol Diagn; 2015 Jul; 17(4):438-45. PubMed ID: 25960256
[TBL] [Abstract][Full Text] [Related]
9. The future in diagnosis and staging of lung cancer. Molecular techniques.
Sienel W; Dango S; Ehrhardt P; Eggeling S; Kirschbaum A; Passlick B
Respiration; 2006; 73(5):575-80. PubMed ID: 17008784
[TBL] [Abstract][Full Text] [Related]
10. A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.
Raz DJ; Ray MR; Kim JY; He B; Taron M; Skrzypski M; Segal M; Gandara DR; Rosell R; Jablons DM
Clin Cancer Res; 2008 Sep; 14(17):5565-70. PubMed ID: 18765549
[TBL] [Abstract][Full Text] [Related]
11. Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.
Boeri M; Sestini S; Fortunato O; Verri C; Suatoni P; Pastorino U; Sozzi G
Expert Rev Mol Diagn; 2015 Jun; 15(6):801-13. PubMed ID: 25924864
[TBL] [Abstract][Full Text] [Related]
12. Understanding prognostic gene expression signatures in lung cancer.
Zhu CQ; Pintilie M; John T; Strumpf D; Shepherd FA; Der SD; Jurisica I; Tsao MS
Clin Lung Cancer; 2009 Sep; 10(5):331-40. PubMed ID: 19808191
[TBL] [Abstract][Full Text] [Related]
13. Three-gene prognostic classifier for early-stage non small-cell lung cancer.
Lau SK; Boutros PC; Pintilie M; Blackhall FH; Zhu CQ; Strumpf D; Johnston MR; Darling G; Keshavjee S; Waddell TK; Liu N; Lau D; Penn LZ; Shepherd FA; Jurisica I; Der SD; Tsao MS
J Clin Oncol; 2007 Dec; 25(35):5562-9. PubMed ID: 18065728
[TBL] [Abstract][Full Text] [Related]
14. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
15. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
16. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
19. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
Wang L; Soria JC; Kemp BL; Liu DD; Mao L; Khuri FR
Clin Cancer Res; 2002 Sep; 8(9):2883-9. PubMed ID: 12231532
[TBL] [Abstract][Full Text] [Related]
20. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
